8I ACQUISITION 2 CORP. : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)

Item 5.07. Submissions of Matters to a Vote of Security Holders.

As previously reported, on April 11, 2022, 8i Acquisition 2 Corp., a British Virgin Islands business company (the "Company" or "LAX"), entered into a Share Purchase Agreement (the "SPA") with Euda Health Limited, a British Virgin Islands business company ("EUDA Health"), Watermark Developments Limited, a British Virgin Islands business company (the "Seller") and Kwong Yeow Liew, acting as Representative of the Indemnified Parties (the "Indemnified Party Representative"). Pursuant to the terms of the SPA, as amended, a business combination between LAX and EUDA Health will be effected through the purchase by LAX of all of the issued and outstanding shares of EUDA Health from the Seller (the "Business Combination").

On November 10, 2022, at 10:00 a.m., Eastern time, the Company held a special meeting of its shareholders of record (the "Special Meeting"), at which the Company's shareholders of record voted on the proposals set forth below, each of which is described in detail in the proxy statement filed with the Securities and Exchange Commission (the "SEC") on October 13, 2022, which was first mailed by the Company to its shareholders on or about October 17, 2022.

As of October 10, 2022, the record date for the Special Meeting, there were 11,073,500 ordinary shares, no par value, of the Company (the "Ordinary Shares") issued and outstanding and entitled to vote at the Special Meeting. A total of 9,369,395 Ordinary Shares, representing approximately 84.61% of the issued and outstanding Ordinary Shares, were present in person by virtual attendance or represented by proxy at the Special Meeting, constituting a quorum for the Special Meeting. The final voting results for each proposal submitted to the shareholders of record of the Company at the Special Meeting are included below.

Each of the proposals described below was approved by the Company's shareholders of record.

PROPOSAL 1:

To approve the transactions contemplated under the SPA.

    For           Against       Abstain      Broker Non-Votes
  8,314,452       1,030,751       24,192                     0




PROPOSAL 2:

To approve and adopt the following amendments and restatements of 8i amended and restated memorandum and articles of association:

a) to amend the name of the combined company from "8i Acquisition 2 Corp." to "EUDA Health Holdings Limited"; and

    For           Against       Abstain      Broker Non-Votes
  8,335,895       1,030,751        2,755                     0




  2

b) to adopt the amended and restated memorandum and articles of association of the combined company (the "Amended and Restated Memorandum and Articles of Association").

    For           Against       Abstain      Broker Non-Votes
  8,335,895       1,030,751        2,755                     0




PROPOSAL 3:

To approve, for purposes of complying with applicable listing rules of the Nasdaq Global Market ("Nasdaq"), the issuance of more than 20% of the issued and outstanding Ordinary Shares and the resulting change in control in connection with the Business Combination.

    For           Against       Abstain      Broker Non-Votes
  8,335,895       1,030,751        2,755                     0




PROPOSAL 4:

To vote to elect five directors effective upon consummation of the Business Combination.

Each of the director nominees received the following votes:

 Director Nominee     Class       For         Withhold
Wei Wen Kelvin Chen   I         8,436,565       932,836
Thien Su Gerald Lim   I         8,436,565       932,836
David Francis Capes   I         8,436,565       932,836
Alfred Lim            II        8,436,565       932,836
Kim Hing Chan         II        8,436,565       932,836

Redemption of Ordinary Shares

As of November 8, 2022, the end of the redemption period for the Ordinary Shares issued as part of the units in the Company's initial public offering consummated on November 24, 2021, an aggregate of 8,195,770 Ordinary Shares were tendered for redemption in connection with the Special Meeting. The final redemption price is $10.0837 per share redeemed.

Item 8.01 Other Events

On November 10, 2022, 8i issued a press release announcing that shareholders that elected to redeem shares in connection with Special Meeting may withdraw such redemption requests by no later than 5:00 p.m. Eastern Time on November 11, 2022. A copy of the press release is attached as Exhibit 99.1.

Item 9.01 Exhibits



Exhibit
  No.                                   Description

99.1        Press Release dated November 10, 2022.
104       Cover Page Interactive Data File (embedded within the Inline XBRL
          document)




  3

© Edgar Online, source Glimpses